Risk of all-cause hospitalization in COPD patients initiating long-acting or short-acting beta agonist therapy

References

• Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006;28:523-32
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of COPD (Revised 2011). Global Initiative for Chronic Obstructive Lung Disease, Inc, 2011. http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Accessed September 17, 2012
   Google Scholar
• Lindberg A, Bjerg A, Bjerg-Bäcklund A, et al. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2006;100:264-72
   PubMed Web of Science ®Google Scholar
• Sandelowsky H, Ställberg B, Nager A, et al. The prevalence of undiagnosed chronic obstructive pulmonary disease in a primary care population with respiratory tract infections – a case finding study. BMC Fam Pract 2011;12:122-30
   PubMed Web of Science ®Google Scholar
• Foster JA, Yawn BP, Maziar A, et al. Enhancing COPD management in primary care settings. MedGenMed 2007;9:24-40
   PubMedGoogle Scholar
• Make B, Dutro MP, Paulose-Ram R, et al. Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients. Int J Chron Obstruct Pulmon Dis 2012;7:1-9
   PubMed Web of Science ®Google Scholar
• Heins-Nesvold J, Carlson A, King-Schultz L, et al. Patient identified needs for chronic obstructive pulmonary disease versus billed services for care received. Int J Chron Obstruct Pulmon Dis 2008;3:415-21
   PubMedGoogle Scholar
• Stuart BC, Simoni-Wastila L, Zuckerman IH, et al. Impact of maintenance therapy on hospitalization and expenditures for Medicare beneficiaries with chronic obstructive pulmonary disease. Am J Geriatr Pharmacother 2010;8:441-53
   PubMedGoogle Scholar
• Barr RG, Bourbeau J, Camargo CA. Tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005;(2):CD002876 . DOI: 10.1002/14651858.CD002876.pub2
   Google Scholar
• Andersson F, Borg S, Jansson SA, et al. The costs of exacerbations in chronic obstructive pulmonary disease (COPD). Respir Med 2002;96:700-8
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TAR, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-52
   PubMed Web of Science ®Google Scholar
• Spencer S, Calverley PMA, Burge PS, et al. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004;23:698-702
   PubMed Web of Science ®Google Scholar
• Connors AF, Jr Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996;154:959-67
   PubMed Web of Science ®Google Scholar
• McGhan R, Radcliff T, Fish R, et al. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007;132:1748-55
   PubMed Web of Science ®Google Scholar
• Schneider KM, O’Donnell BE, Dean D. Prevalence of multiple chronic conditions in the United States’ Medicare population. Health Qual Life Outcomes 2009;7:82-92
   PubMed Web of Science ®Google Scholar
• Research Data Assistance Center Website. School of Public Health, Health Policy and Management, Minneapolis, MN: University of Minnesota, 2012. http://www.resdac.org Accessed September 17, 2012
   Google Scholar
• Holguin F, Folch E, Redd SC, et al. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005;128:2005-11
   PubMed Web of Science ®Google Scholar
• Camilli AE, Robbins DR, Lebowitz MD. Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol 1991;133:795-800
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83
   PubMedGoogle Scholar
• Nannini L, Cates CJ, Lasserson TJ, et al. Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007;(4):CD003794 . DOI: 10.1002/14651858.CD002876.pub2
   Google Scholar
• Jones PW, Wilson K, Sondhi S. Cost-effectiveness of salmeterol in patients with chronic obstructive pulmonary disease: an economic evaluation. Respir Med 2003;97:20-6
   PubMed Web of Science ®Google Scholar
• Celli BR. Update on the management of COPD. Chest 2008;133:1451-62
   PubMed Web of Science ®Google Scholar
• Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009;360:1418-28
   PubMed Web of Science ®Google Scholar
• United States Congress. Patient Protection and Affordable Care Act. Sect. 3025, 2010. Washington, DC: United States Congress. 111-48. http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdf. Accessed September 17, 2012]
   Google Scholar
• Chan FWK, Wong FYY, Yam CHK, et al. Risk factors of hospitalization and readmission of patients with COPD in Hong Kong population: analysis of hospital admission records. BMC Health Serv Res 2011;11:186
   PubMed Web of Science ®Google Scholar
• Moretti AM, Tafuri S, Parisi D, et al. Epidemiology and costs of hospital care for COPD in Puglia. Multidiscip Respir Med 2011;6:299-304
   Google Scholar
• Lorenz KA, Asch SM, Yano EM, et al. Comparing strategies for United States veterans’ mortality ascertainment. Popul Health Metr 2005;3:2
   Google Scholar
• Macchai A, Monte S, Romero M, et al. The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure. Eur J Heart Fail 2007;9:942-8
   Google Scholar